Satixime-CL-LB
Description_Effects
Satixime-CL-LB is a broad-spectrum antibiotic combination containing Cefixime, Cloxacillin, and Lactobacillus, designed to treat a wide range of bacterial infections effectively while supporting digestive health. Cefixime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to the destruction of infection-causing bacteria. Cloxacillin, a penicillin-class antibiotic, is particularly effective against penicillinase-producing staphylococci and works by inhibiting bacterial cell wall formation as well. The combination of Cefixime and Cloxacillin provides enhanced antibacterial coverage, making Satixime-CL-LB highly effective in treating respiratory tract infections, skin and soft tissue infections, bone and joint infections, ENT infections, and urinary tract infections. This dual action helps target both gram-positive and gram-negative bacteria, especially in resistant or mixed infections. To minimize antibiotic-induced gastrointestinal disturbances, Lactobacillus, a probiotic, is included. It helps restore the natural balance of gut flora disrupted by antibiotic therapy, thereby preventing symptoms like diarrhea, bloating, and indigestion. Satixime-CL-LB should be taken as prescribed by a healthcare professional. Completing the full course is important to avoid recurrence or antibiotic resistance. Mild side effects may include stomach upset, nausea, or allergic reactions. It is especially useful in infections requiring robust and multi-angle antibiotic coverage.
